Related Experiment Video
Updated: Feb 4, 2026

Identifying Protein-protein Interaction Sites Using Peptide Arrays
Published on: November 18, 2014
Protein-protein interactions reveal key canonical pathways, upstream regulators, interactome domains, and novel
Ina Dervishi1, Oge Gozutok1, Kevin Murnan1
1Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, USA.
Abstract:
Developing effective treatment strategies for neurodegenerative diseases require an understanding of the underlying cellular pathways that lead to neuronal vulnerability and progressive degeneration. To date, numerous mutations in 147 distinct genes are identified to be "associated" with, "modifier" or "causative" of amyotrophic lateral sclerosis (ALS). Protein products of these genes and their interactions helped determine the protein landscape of ALS, and revealed upstream modulators, key canonical pathways, interactome domains and novel therapeutic targets. Our analysis originates from known human mutations and circles back to human, revealing increased PPARG and PPARGC1A expression in the Betz cells of sALS patients and patients with TDP43 pathology, and emphasizes the importance of lipid homeostasis. Downregulation of YWHAZ, a 14-3-3 protein, and cytoplasmic accumulation of ZFYVE27 especially in diseased Betz cells of ALS patients reinforce the idea that perturbed protein communications, interactome defects, and altered converging pathways will reveal novel therapeutic targets in ALS.
Insights
Understanding cellular pathways is key for neurodegenerative disease treatments like amyotrophic lateral sclerosis (ALS). This study highlights lipid homeostasis and protein interactions as crucial for identifying new therapeutic targets in ALS.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), are characterized by neuronal vulnerability and degeneration.
- Over 147 genes have been linked to ALS, providing insights into its complex protein landscape.
- Understanding cellular pathways is crucial for developing effective ALS treatments.
Purpose of the Study:
- To investigate the protein landscape and cellular pathways associated with amyotrophic lateral sclerosis (ALS).
- To identify novel therapeutic targets by analyzing gene mutations and their protein products in ALS patients.
Main Methods:
- Analysis of known human gene mutations associated with ALS.
- Examination of protein products, interactions, and canonical pathways.
- Assessment of gene expression in Betz cells of sALS patients and those with TDP43 pathology.
Main Results:
- Identified increased expression of PPARG and PPARGC1A in Betz cells of ALS patients, emphasizing lipid homeostasis.
- Observed downregulation of YWHAZ (a 14-3-3 protein) and cytoplasmic accumulation of ZFYVE27 in diseased Betz cells.
- Revealed perturbed protein communications and interactome defects in ALS.
Conclusions:
- Altered lipid homeostasis and protein interactions are significant in ALS pathogenesis.
- Perturbed protein communications and converging pathways offer novel therapeutic targets for ALS.
- Further research into these pathways may lead to effective ALS treatment strategies.
More Related Videos
Related Concept Videos
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Conservation of Protein Domains
Non-Canonical Wnt Signaling Pathways

